top of page
Search

The DEA Just Ordered 30 Kilograms of 5-MeO-DMT. Here's Why That Matters.

Let that sink in for a second.


The Drug Enforcement Administration, the same agency that's spent decades locking people up for psychedelics, just authorized the legal manufacturing of thirty thousand grams of 5-MeO-DMT. In a single year.


On January 5th, the DEA published its final aggregate production quotas for 2026. Most people glanced at the cannabis numbers and moved on. But buried in the Federal Register, the psychedelic numbers went through the roof.


I've been watching these quotas for years. This one stopped me cold.


The Numbers That Changed Everything


Here's what the DEA approved for 2026, compared to last year:



MDMA, LSD, mescaline, and ibogaine? Unchanged.


Read that list again. Psilocybin gets the headlines because everyone knows mushrooms. But look at 5-MeO-DMT. Look at methylone. Those aren't incremental bumps. Those are signals.


Here's the historical context that blows my mind:


In 2021, the DEA quota for 5-MeO-DMT was 35 grams. Thirty-five. You could hold the entire year's authorized supply in your hand.


That's an 857x increase in five years.


Eight hundred and fifty-seven times more 5-MeO-DMT being manufactured, legally, under federal supervision. Something fundamental has changed.


To put that in perspective: a full-release 5-MeO-DMT dose is somewhere between 12 and 17 milligrams. Thirty kilograms is thirty million milligrams. That's enough raw material for roughly 1.8 to 2.5 million full-release doses.


Nobody is administering 2.5 million ceremonies. The material goes to pharmaceutical manufacturing, analytical testing, stability studies, and clinical trial supply chains. Most of it never touches a human being. But the sheer scale tells you something about the ambition behind the research.



Why This Is Happening Now


Two words: clinical trials.


GH Research, an Irish biotech company, has been developing GH001, a synthetic inhalable form of 5-MeO-DMT for treatment-resistant depression. Their Phase 2 trials require large quantities of pharmaceutical-grade material. They're not the only ones.


That single development explains a huge chunk of the 5-MeO-DMT quota increase. Clinical trials don't run on milligrams. They need kilograms, manufactured to pharmaceutical standards, in DEA-licensed facilities.


On the psilocybin side, Compass Pathways, the biggest player in psychedelic pharmaceuticals, continues running its Phase 3 trials for treatment-resistant depression. USONA Institute is pursuing psilocybin for major depressive disorder. Dozens of smaller trials are recruiting patients across the country.


And methylone? That 477% increase reflects a push toward MDMA alternatives after the FDA rejected MDMA-assisted therapy in 2024. Researchers pivoted. The funding followed.


Here's what most people miss: these final numbers are actually higher than what the DEA originally proposed. Public comments pushed them up. Researchers made the case that the initial quotas weren't enough to support the trials already underway. The DEA listened.


What the Government Is Really Saying


Strip away the bureaucratic language and here's what's happening: the United States government is investing in the infrastructure to study psychedelics at scale.


That sentence would have been science fiction ten years ago.


The DEA doesn't set these quotas because they've gotten soft on drugs. They set them because FDA-authorized research demands raw material. Every gram in that quota exists because a clinical trial has been approved, a research protocol submitted, and a licensed manufacturer contracted to produce it.


Is the system slow? Absolutely. Is it frustrating to watch compounds that have helped people for decades remain Schedule I? Every single day. But the machinery is moving, and the numbers show exactly which direction.


Why 5-MeO-DMT Matters to Me


I'll be straight with you. I have skin in this game.


As a 5-MeO-DMT integration coach, I work with men who are processing some of the most powerful experiences a human being can have. A single 5-MeO session can crack open everything you thought you knew about yourself. That's not a metaphor. It's what happens.


The integration work that follows is where real change happens. Right now, that work exists in a gray area. Most people who've experienced 5-MeO-DMT did so outside clinical settings, in contexts that range from carefully held ceremonies to completely unsupported situations.


Thirty kilograms of research material means more clinical trials. More trials mean more data. More data means a clearer path toward legal, regulated access with proper support.


This isn't abstract policy for me. It's the foundation of better outcomes for the men I work with.


What This Means for You


If you're someone who has experienced 5-MeO-DMT or is considering it, here's the practical takeaway:


More research is coming. A lot more. The next two to three years will produce more clinical data on 5-MeO-DMT than the previous fifty years combined.


The stigma is shifting. When the DEA authorizes 30 kilograms of a Schedule I psychedelic for research, it signals institutional acceptance that these compounds have therapeutic value.


The path to legal access is getting clearer. We're not there yet. Every quota increase, every completed trial, every positive outcome moves the needle.


And integration coaching, the work of making sense of these experiences and turning insight into lasting change, will only become more important as access expands.



Looking Forward


I don't want to oversell this. A production quota isn't legalization. Clinical trials fail. Regulatory timelines slip. The path from here to approved psychedelic medicines is measured in years, not months.


The trajectory is clear though. The numbers don't lie. From 35 grams to 30,000 grams in five years. From fringe research to Phase 2 clinical trials at major institutions. From taboo to production quotas published in the Federal Register.


For those of us who've been in this space, who've seen what these compounds can do for people who are suffering, this is the kind of news that keeps you going.


The DEA ordered 30 kilograms of 5-MeO-DMT. And that matters more than most people realize.


Sources



This article is for educational purposes only. It is not medical or legal advice. Psychedelic substances remain Schedule I under federal law in the United States.


Interested in 5-MeO-DMT integration?

If you've had a 5-MeO-DMT experience and want skilled support making sense of it, Adult in Training offers integration coaching for men. Grounded, practical, judgment-free. Sliding scale available.

 
 
 

Recent Posts

See All
bottom of page